Prof Clarke (The Christie Hospital, Manchester, UK) chairs a discussion with Prof Efstathiou (MD Anderson Cancer Center, Houston, USA), Prof Mottet (University Hospital, Saint-Étienne, France),  and Prof Costa (University of Lisbon, Lisbon, Portugal) for ecancertv about the latest advancements in prostate cancer treatment.

They consider how the integration of concepts can inform the development of treatment strategies for advanced prostate cancer, looking at high-risk locally advanced disease, metastatic hormone sensitive disease, and the management of older patients.

This programme has been supported by an unrestricted educational grant from Janssen Pharmaceutica (A Johnson & Johnson Company).